申请人:Eli Lilly and Company
公开号:US07838543B2
公开(公告)日:2010-11-23
The present invention relates to a melanin concentrating hormone antagonist compound of formula (I); wherein Ar1, L1, R1, q, X, R2, R3, R4, and R5 are as defined, or a pharmaceutically acceptable salt, solvate, or enantiomer thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.
本发明涉及一种公式(I)的黑色素浓集激素拮抗剂化合物;其中Ar1,L1,R1,q,X,R2,R3,R4和R5如定义所述,或其药学上可接受的盐,溶剂化合物或对映体,用于治疗、预防或改善与肥胖和相关疾病相关的症状。